NAFDAC cautions against use of Covifor Remidesivir Injection, says product is suspicious
The National Agency for Food and Drug Administration and Control (NAFDAC) has warned the general public not to use ‘Covifor Remidesivir 100 mg Injection for treatment of any illness. The ...


















